Marie Bosslett, Assistant Editor

Before Revolutionizing Atopic Dermatitis 2026 begins, take a look back at the data, debates, and patient stories that defined last year’s Nashville meeting.

Microneedle SkinJect patch aims to clear basal cell carcinoma without surgery, showing phase 2 promise and expanding to Gorlin syndrome trials.

Dissolvable microneedles deliver doxorubicin to basal cell lesions, showing promising phase 2 clearance and opening hope for Gorlin syndrome patients.

Avalo readies long-acting AVTX-010 to target hidradenitis suppurativa, aiming for fewer injections for patients after strong phase 2 abdakibart results.

Michael Ingrassia, PhD, and Ida Wong, MBA, speak about the brand's new line, pairing clinically tested soothing skin care with makeup to calm reactive skin, strengthen the barrier, and ease redness-related stress.

As Darrell Rigel, MD, MS, notes, bemotrizinol will deliver photostable broad-spectrum UVA/UVB protection with better cosmetic feel, low absorption, and pave the way for more advanced US sunscreens.

IL-4Rα blocker stapokibart cleared chronic spontaneous urticaria and improved quality of life after omalizumab failure in a 44-year-old female patient.

Does this structured nighttime skin care routine actually work or is it just a myth? Read more about the latest social media trend and learn how to counsel your patients in the clinic.

Learn how today’s aesthetic care is shifting to prevention through skin care, retinoids, lasers, and conservative fillers for natural, refreshed aging.

Amy Snow, MSPAS, PA-C, speaks about her collaboration with wellness influencer to fight TikTok skin care myths and share diet-smart acne tips for teens.

Younger patients are embracing preventative injectables and skin care; Shawna Jones, PA-C, urges evidence-based, personalized plans to cut through social-media hype.

Amy Snow, MSPAS, PA-C's mobile nonprofit brings free acne treatment, education, and hope to underserved teens.

FDA clears lebrikizumab (EBGLYSS) every-8-week maintenance dosing for moderate to severe atopic dermatitis, reducing maintenance injections to as few as 6 per year.

This review of the latest dermatological studies includes insights on a mobile AI platform for skin disease prescreening, COVID-19 outcomes in PsO patients on biologics, i-PRF) and laser therapy for facial rejuvenation, and more.

Meta-analysis finds azithromycin pulse therapy matches doxycycline for moderate to severe acne, with fewer GI adverse events and less photosensitivity.

Dual-layer microneedle patch delivers fast itch relief and sustained methotrexate-zinc therapy, improving psoriasis inflammation, immune balance, and infection protection in mice.

AI analysis of 187,016 menopausal women links hair loss severity to thyroid disease, gut symptoms, scalp inflammation, and genetics, supporting broader diagnostic workups beyond hormones.

As Epiduo goes OTC, offering once-daily adapalene+BPO for mild to moderate acne, Heather Woolery-Lloyd, MD, FAAD, gives advice on irritation, purging, and simplifying routines.

Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series.

Can daily supplements "clear skin from within", or is it just a myth? Read more about the latest social media trend and learn how to counsel your patients in the clinic.

Suneel Chilukuri, MD, explains why acne care requires a holistic approach that treats both visible lesions and the "mental scarring" that affects patient self-confidence.

Plant-based oat oil and aloe moisturizer outperforms metronidazole in a 12-week trial, reducing rosacea redness and lesions safely without irritation.

Learn why non-comedogenic moisturizers and hyaluronic acid support the skin barrier in acne patients, plus how patients can use benzoyl peroxide safely.

Discover how tailored pre- and postmicroneedling care, plus lactobacillus exosome boosters, may speed healing, improve scars, and deliver safe, FDA-cleared results.

Medicus Pharma advances microneedle doxorubicin therapy to clear multiple Gorlin syndrome BCC lesions.

This review of the latest dermatological studies includes insights on PeakPASI in psoriasis severity, the future of digital derm lectures, negative pressure wound therapy, and more.

Michael Gold, MD, explains why the brand's microneedling pen stands out, with customizable depth, speed, and cartridges for rejuvenation and acne-scar treatment credibility.

New IND pushes QRX003 toward first targeted therapy for peeling skin syndrome, with early pediatric results showing rapid healing and no safety issues.

Explore top dermatology conferences and meetings in June 2026 and let us know which ones you'll be attending!

Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series.